Contact Us

marketing@medicilon.com

|

中

|

close search icon

中

Company Profile

Corporate Culture

Management Team

Company History

Message from the CEO

Honors and Awards

Over 20 years of experience in R&D

01 Drug Discovery

Chemistry Research

Biology Research

Early Pharmacokinetics

02 Pharmaceutical Research

Active Pharmaceutical Ingredients

Pharmaceutical preparation

Analytical Method Development and Quality Control

Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics

Drug Safety Evaluation

01 One-stop Integrated Services

Liposome Drug Development

Pharmaceutical Research

Preclinical Research

Botanical Drug Preclinical R&D

02 Innovative Drug Services

Cellular Immunotherapies

Nucleic Acid Drug

Peptide Drug Conjugate (PDC)

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection

Metabolite Identification (MetID)

Drug Forming Research

Flow Cytometry Technology

SEND Format Conversion

NanoString nCounter Detection

Routes of Drug Administration

04 Drug Efficacy Evaluation for Common Diseases

IO Pharmacodynamic Model

Inflammatory and Immune Diseases

Rodent Cerebrovascular Disease

05 Advanced Preparation R&D

Inhalation drug

Ophthalmic drug

Skin Topical Preparation

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service

GLP-1 New Drug R&D Service

KRAS-targeted Drugs R&D Service

Talent Development

Campus Recruitment

Campus Recruitment

Campus Recruitment

Medicilon Events

Featured Stories

2024-07-22Medicilon Events

The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together

On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.

2024-07-22Medicilon Events

5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"

Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.

Stock Information

Investment Contact

Medicilon 688202

RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

Intellectual Property Protection

Clients Testimonials

Medicilon Support

U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

ABOUT
Company Profile Management Team Honors and Awards Corporate Culture

SERVICES
Drug Discovery Pharmaceutical Research Preclinical Research

PLATFORM
One-stop Integrated Services Innovative Drug R&D Services Key Technical Services for Drug R&D Drug Efficacy Evaluation for Common Diseases High-end Preparations Technology Platform Targeted Drugs R&D Services Public Services Platform

CAREERS
Talent Development Recruitment

NEWS
Medicilon Events Featured Stories Market Events Videos A.C.E.

INVESTORS
Stock Information Investment Contact

CLIENT CENTER
Intellectual Property Protection Clients Testimonials Downloads Partnerships Medicilon Support Newsletters

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 |Website Map

关闭

中

Message

Contact Us

Business Inquiry

Global：

Email:marketing@medicilon.com

+1(626)986-9880(U.S.)

0044 7790 816 954 (Europe)

China：

Email: marketing@medicilon.com.cn

Tel: +86 (21) 5859-1500

Back To Top

Online Message×

News and Events

Medicilon Events Featured Stories Market Events Videos A.C.E.

HomenewsFeatured Stories

Featured Stories

Hot information：

Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021

Overview of the Drug Discovery Process

The steps of drug discovery can be simply summarized as disease→target→hit→lead→candidate→drug.

Overview of the Drug Discovery Process

The Special Effects Channel Leading to the Fight Against the New Crown - Paxlovid

Pfizer's Paxlovid (Paxlovid) oral drug for the new crown will be launched for the first time at the end of 2021. Until February this year, the official website of China's State Food and Drug Administration released the important news of the drug's import registration, which will be included in the medical insurance payment system shortly. The time was sensational.

The Special Effects Channel Leading to the Fight Against the New Crown - Paxlovid

Stability Studies of Pharmaceuticals

Medicilon has extensive experience of performing stability studies on active pharmaceutical ingredients, early prototype formulations and finished dosage forms. Stability testing is performed according to FDA-ICH guidelines, client approved protocols and standard operating procedures.

Stability Studies of Pharmaceuticals

Pharmaceutical Preformulation Studies

Medicilon offers a full spectrum of Pharmaceutical Preformulation testing capabilities. Medicilon has wide knowledge in pharmaceutical preformulation studies.

Pharmaceutical Preformulation Studies

Indirect Fluorescent Antibody Test

Indirect Fluorescent Antibody is to use a specific antibody to react with the corresponding antigen in the specimen, and then use a fluorescein-labeled secondary antibody (anti-antibody) to bind to the primary antibody in the antigen-antibody complex, and observe the specificity under a fluorescence microscope after washing.

Indirect Fluorescent Antibody Test

Medicilon MPTP Parkinson Disease Model

Medicilon has effective models for evaluating new drugs for Parkinson, including MPTP-induced mouse subacute PD model, MPTP+ probenecid-induced mouse chronic PD model, oxytremorine-induced cholinergic symptom model, etc.

Medicilon MPTP Parkinson Disease Model

In Vivo Tumor Models

Medicilon boasts nearly 300 in vivo tumor models. At the same time, we are empowering innovative therapies to comprehensively evaluate and study immuno-oncology.

<i>In Vivo</i> Tumor Models

What is ADME? ADME means absorption, distribution, metabolism and excretion of drugs in organisms.

What is ADME?

Commonly Used Mouse and Nude Mouse Tumor Model

In animal tumor transplantation models, Kunming mice or purebred mice are often used to inoc-ulate mouse tumors, and the inhibitory effect of the test substance on tumor growth is observed.

Commonly Used Mouse and Nude Mouse Tumor Model

Nude Mice Animal Model

Nude mice are immunodeficient animals because they have no thymus glands, so they lack immune response. Medicilon Pharmacology Service provides you with experiments on tumor formation in nude mice and subcutaneous tumor formation in nude mice.

Nude Mice Animal Model

prev
1
2
3
4
5
6
7
8
9
10
11
next

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy

-->